Heron Therapeutics (HRTX) Debt to Equity (2016 - 2026)
Heron Therapeutics (HRTX) reported Debt to Equity of $11.85 for Q1 2026, up 1437.69% on a YoY basis from $0.77 in Q1 2025, and up 57.46% quarter-over-quarter from $7.53 in Q4 2025.
Heron Therapeutics (HRTX) Debt to Equity (2016 - 2026) Analysis & Trends
Heron Therapeutics has reported Debt to Equity for 6 years, with the latest figure at $11.85 in Q1 2026.
- For the quarter ending Q1 2026, Debt to Equity rose 1437.69% year-over-year to $11.85; the trailing twelve-month figure through Mar 2026 stood at $11.85 (up 1437.69% YoY), and the FY2025 full-year result was $7.53, up 1112.25% from the prior year.
- Debt to Equity for Q1 2026 stood at $11.85, up from $7.53 in the prior quarter.
- The five-year high for Debt to Equity was $11.85 in Q1 2026, with the low at -$0.89 in Q1 2025.
- Historically, Debt to Equity has averaged $2.14 across 4 years, with a median of -$0.68 in 2024.
- Annual changes were most pronounced in 2025 — Debt to Equity fell 22.39% — and 2026, when it surged 1437.69%.
- Heron Therapeutics' Debt to Equity stood at -$0.71 in 2023, then retreated by 4.13% to -$0.74 in 2024, then soared by 1112.25% to $7.53 in 2025, then surged by 57.46% to $11.85 in 2026.
- The last three Debt to Equity figures came in at $11.85 (Q1 2026), $7.53 (Q4 2025), and $7.22 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 0.32 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Heron Therapeutics | 85.57 Mn | 55.60 Mn | 24.07 Mn | 11.85 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.85 |
| Dec 31, 2025 | 7.53 |
| Sep 30, 2025 | 7.22 |
| Mar 31, 2025 | -0.89 |
| Dec 31, 2024 | -0.74 |
| Sep 30, 2024 | -0.62 |
| Jun 30, 2024 | -0.65 |
| Mar 31, 2024 | -0.72 |
| Dec 31, 2023 | -0.71 |
| Sep 30, 2023 | -0.86 |
| Dec 31, 2017 | 0.19 |
| Sep 30, 2017 | 0.62 |
| Jun 30, 2017 | 0.36 |
| Mar 31, 2017 | 0.49 |
| Dec 31, 2016 | -2.35 |
| Sep 30, 2016 | 2.80 |